Selected stage IV rectal cancer patients managed by the watch‐and‐wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
Authors:
- Petra A. CustersPCPetra A. Custers
- Britt J. P. HupkensBHBritt J. P. Hupkens
- Brechtje A. GrotenhuisBGBrechtje A. Grotenhuis
- Koert F. D. KuhlmannKKKoert F. D. Kuhlmann
- Stéphanie O. BreukinkSBStéphanie O. Breukink
- Geerard L. BeetsGBGeerard L. Beets
- Jarno MelenhorstJMJarno Melenhorst
- the Dutch Watch‐and‐Wait Consortium (collaborators)T(the Dutch Watch‐and‐Wait Consortium (collaborators)
Open Access
- 21 January 2022
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 24 (4) , 401-410
Abstract
Aim: The aim of this study was to assess the clinical and oncological outcome of a selected group of stage IV rectal cancer patients managed by the watch‐and‐wait approach following a (near‐)complete response of the primary rectal tumour after radiotherapy.Method: Patients registered in the Dutch watch‐and‐wait registry since 2004 were selected when diagnosed with synchronous stage IV rectal cancer. Data on patient characteristics, treatment details, follow‐up and survival were collected. The 2‐year local regrowth rate, organ‐preservation rate, colostomy‐free rate, metastatic progression‐free rate and 2‐ and 5‐year overall survival were analysed.Results: After a median follow‐up period of 35 months, local regrowth was observed in 17 patients (40.5%). Nine patients underwent subsequent total mesorectal excision, resulting in a permanent colostomy in four patients. The 2‐year local regrowth rate was 39.9%, the 2‐year organ‐preservation rate was 77.1%, the 2‐year colostomy‐free rate was 88.1%, and the 2‐year metastatic progression‐free rate was 46.7%. The 2‐ and 5‐year overall survival rates were 92.0% and 67.5%.Conclusion: The watch‐and‐wait approach can be considered as an alternative to total mesorectal excision in a selected group of stage IV rectal cancer patients with a (near‐)complete response following pelvic radiotherapy. Despite a relatively high regrowth rate, total mesorectal excision and a permanent colostomy can be avoided in the majority of these patients.Keywords
This publication has 25 references indexed in Scilit:
- Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysisThe Lancet Oncology, 2016
- Colorectal cancer with synchronous hepatic metastases: Systematic review of reports comparing synchronous surgery with sequential bowel-first or liver-first approachesEuropean Journal of Surgical Oncology, 2016
- Long-term Results of the “Liver First” Approach in Patients With Locally Advanced Rectal Cancer and Synchronous Liver MetastasesDiseases of the Colon & Rectum, 2013
- Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal CancerJournal of Clinical Oncology, 2011
- Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based seriesColorectal Disease, 2010
- Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for StandardizationDiseases of the Colon & Rectum, 2010
- Patient and Physician Preferences for Surgical and Adjuvant Treatment Options for Rectal CancerArchives of Surgery, 2008
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancerBritish Journal of Surgery, 2006
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution studyGut, 2000